The Liver as a Critical Point in Ivermectin and Fenbendazole Protocols.

A spike in ALT/AST enzymes isn't always a sign of drug toxicity—it’s often a logistical signal that the liver is overloaded with filtering cellular debris from tumor breakdown (Tumor Lysis Syndrome). During aggressive metabolic pressure, a 20-30% increase in enzyme levels reflects the current filter load, not necessarily a reason to halt therapy.

Understanding this logistics is critical to avoid making premature decisions during the most effective phases of the protocol.